Literature DB >> 33911682

The face of CD4+ Hydroa Vacciniforme-Like Lymphoproliferative Diseases: The Shadow of Systemic T-Cell Lymphoma.

Young Jae Kim1, Myoung Eun Choi1, Woo Jin Lee1, Sung Eun Chang1, Jee Ho Choi1, Mi Woo Lee1.   

Abstract

Entities:  

Year:  2019        PMID： 33911682      PMCID： PMC7997080          DOI： 10.5021/ad.2019.31.S.S17

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

1.  Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents.

Authors:  Young Jae Kim; Sun Young Choi; Woo Jin Lee; Chong Hyun Won; Sung Eun Chang; Jee Ho Choi; Mi Woo Lee
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-06-20       Impact factor: 3.135

2.  Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.

Authors:  Jin Ho Paik; Ji-Young Choe; Hyojin Kim; Jeong-Ok Lee; Hyoung Jin Kang; Hee Young Shin; Dong Soon Lee; Dae Seog Heo; Chul-Woo Kim; Kwang-Hyun Cho; Tae Min Kim; Yoon Kyung Jeon
Journal:  Leuk Lymphoma       Date:  2016-05-09

Review 3.  Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature.

Authors:  Yu-Qiong Yang; Lei Fan; Li Wang; Ji Xu; Run Zhang; Zheng Ge; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 4.  Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.

Authors:  Lindsay A Eminger; Lawrence David Hall; Kathleen S Hesterman; Warren R Heymann
Journal:  J Am Acad Dermatol       Date:  2015-01       Impact factor: 11.527

5.  Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.

Authors:  Ken-ichi Imadome; Misako Yajima; Ayako Arai; Atsuko Nakazawa; Fuyuko Kawano; Sayumi Ichikawa; Norio Shimizu; Naoki Yamamoto; Tomohiro Morio; Shouichi Ohga; Hiroyuki Nakamura; Mamoru Ito; Osamu Miura; Jun Komano; Shigeyoshi Fujiwara
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.